Intravenous immunoglobulin for the treatment of Alzheimer’s disease: current evidence and considerations

Alzheimer’s disease (AD) is a devastating neurodegenerative form of dementia with increasing incidence rates in most countries. AD is characterized by amyloid plaques and neurofibrillary tangles in the brains of AD individuals accompanied by global neuronal loss. The peptide amyloid-β (Aβ) aggregate...

Descripción completa

Detalles Bibliográficos
Autores principales: Schindowski, Christina, Zimmermann, Jürgen, Schindowski, Katharina
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2014
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7337175/
https://www.ncbi.nlm.nih.gov/pubmed/32669906
http://dx.doi.org/10.2147/DNND.S51786

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7337175/
https://www.ncbi.nlm.nih.gov/pubmed/32669906
http://dx.doi.org/10.2147/DNND.S51786

Ejemplares similares